Financhill
Buy
71

ABBV Quote, Financials, Valuation and Earnings

Last price:
$211.73
Seasonality move :
3.23%
Day range:
$208.29 - $212.82
52-week range:
$153.58 - $218.66
Dividend yield:
2.97%
P/E ratio:
88.24x
P/S ratio:
6.67x
P/B ratio:
112.44x
Volume:
4.5M
Avg. volume:
6.2M
1-year change:
16.87%
Market cap:
$373.8B
Revenue:
$56.3B
EPS (TTM):
$2.40

ABBV Analysts' Consensus Rating

The 21 analysts providing 12-month price projections for AbbVie shares anticipate an average target of $211.73, ranging from a low estimate of $173.00 to a high estimate of $250.00. This average target implies a growth of -0.02% compared to the current stock price of $211.77.

Consensus Price Target

$211.73

Highest Price Target

$250.00

Lowest Price Target

$173.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 10 12 11

Hold 8 10 10

Sell 0 0 0
Consensus Buy Buy Buy

ABBV Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Goldman Sachs Stock a Buy Sell or Hold?
Is Goldman Sachs Stock a Buy Sell or Hold?

When the Federal Reserve started hiking rates in 2022, banks’…

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock